Michael J. McGinley, Presi, Biologic. & Pharm at HESKA CORP (HSKA), sold 9,499 shares at $15.45 ($147K) on 2014-11-21, disclosed to the SEC on 2014-11-25.
Open-market sale of $147k HSKA by Presi, Biologic. & Pharm. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.45 | 235 | $4K | 2.5% |
| 2 | $15.45 | 9,264 | $143K | 97.5% |
| Total | $15.45 avg | 9,499 | $147K | 100% |
| Filing → |
| HSKA | SELL | 2017-06-01 | $2.2M | — | Filing → |
| HSKA | SELL | 2016-11-09 | $729K | — | Filing → |
| HSKA | SELL | 2016-05-10 | $219K | — | Filing → |